Antineuronal Nuclear Antibody Type 3 (ANNA-3) What is Antineuronal Nuclear Antibody Type 3? Antineuronal Nuclear Antibody Type 3 (ANNA-3) is an autoantibody—a type of immune protein that mistakenly targets the body’s own nervous system. Specifically, ANNA-3 targets proteins found in the nuclei of nerve cells. It is classified as a paraneoplastic antibody, meaning it can be associated with an immune response triggered by an underlying cancer. Why is ANNA-3 Important? ANNA-3 is used to help diagnose paraneoplastic neurologic syndromes (PNS)—rare disorders in which the immune system attacks the nervous system in response to a cancer located elsewhere in the body. These neurological symptoms often appear before the cancer is diagnosed, making early detection of ANNA-3 an important clue for doctors. What Does a Positive ANNA-3 Result Mean? A positive ANNA-3 result suggests that the body may be mounting an autoimmune response linked to a hidden (occult) tumor. This antibody has been found in patients with: Lung cancer, especially small cell lung cancer Breast cancer Other solid tumors However, a positive result does not confirm cancer on its own—it simply signals that further testing (such as imaging or cancer screening) may be needed. What Are the Symptoms Linked to ANNA-3? If ANNA-3 is present, a person may experience neurological symptoms such as: Memory loss or confusion (encephalopathy) Seizures Balance or coordination problems (ataxia) Numbness or tingling (neuropathy) Muscle weakness These symptoms result from inflammation or damage to the nervous system caused by the immune response—not the cancer itself. What Does a Negative ANNA-3 Result Mean? A negative ANNA-3 result means this specific antibody was not detected. However, this does not rule out all possible paraneoplastic or autoimmune conditions. If symptoms persist, other antibody tests or imaging studies may still be appropriate. Summary Antineuronal Nuclear Antibody Type 3 (ANNA-3) is a marker that can signal an autoimmune reaction related to a hidden cancer. It is most often used when unexplained neurological symptoms are present. A positive result is a sign that further investigation is needed to rule out or diagnose an underlying malignancy and manage any related nerve damage early. Always consult your doctor or neurologist to interpret your results and decide on the next steps.

Antinuclear Antibodies (ANA) are a group of autoantibodies that target substances found in the nucleus of a cell. The ANA screen is a preliminary test used to detect the presence of these antibodies in the blood, which may indicate the presence of an autoimmune disorder. When an ANA screen yields a positive or indeterminate result, a Reflex ANA IFA (Indirect Fluorescent Antibody) test may be performed for a more detailed analysis. This test can identify specific patterns of fluorescence that correlate with various types of autoimmune diseases. Additionally, the detection of double-stranded DNA (dsDNA) antibodies, through a reflex test, is especially significant as these are highly specific for systemic lupus erythematosus (SLE), a chronic autoimmune disease. The presence of dsDNA antibodies can be indicative of the disease activity and severity. Therefore, the combination of these tests aids clinicians in diagnosing, monitoring, and managing autoimmune conditions, although the results are always considered in the broader context of clinical symptoms and other diagnostic findings.